| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-08 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
2e-08 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-08 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-08 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
4e-08 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-07 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-07 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
2e-07 |
| mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
| mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
3e-07 |